Gland Pharma Limited IPO Message Board (Page 14)

This company if it lists at 1500 will have market cap to be among top 15 pharma companies on basis of market cap

AND

In top 100 companies on basis of market cap on listing at 1500. Which means after 31st January 2021 , it can become part of all large cap mutual fund by way of definition. On basis of free float and if volume is there it can find entry into Nifty Next 50

Mark my words. Good listing and bumper returns in long term . It is amongst the highest growth pharma companies .listing maybe around 1550 -1600 but in next 6 months it will cross 2200.

BIGGEST FLOP IPO - BY RETAIL INVESTORS....
WELL DONE RETAIL INVESTORS.

And you still thinking LMs and Promoters are really care about RII? They are here for business, who cares emotions.

LM stooges who was very active few days vanished now seems ...

Seedhi si baat hein
RII & HNI Aapne paise se
QIB Anyo ke paiso se

Considering the size of the issue and the negative sentiments ,the subscription figures were OK. Not great or good, but just OK. There may not be any listing gain, but for medium term it appears to be a good investment.

Gland Pharma IPO

LAST Day at 6:00PM

The following data is assuming the shares will be issued at @1,500/- (upper price band)

QIB*: 06.40X (*Excluding Anchor)
NII: 00.51X
RII: 00.24X
Total: 02.06X

*RII Applications: 2.00L* Approx
No. of Applic-wise: 00.13X


Gland Pharma IPO
GMP 25 +/- 1

See good news is that the very intelligent mutual fund investor has subscribed in good amount as per BSE website

GLAND PHARMA LTD
Last updated on
11 Nov 2020 | 06:00:00 PM
Sr.No.      Category      No.of shares offered / reserved      No. of shares bid for      No. of times of total meant for the category
1      Qualified Institutional Buyers (QIBs)      86,39,394      4,15,52,830      4.8097
1(a)      Foreign Institutional Investors (FIIs)      -      2,15,75,330      
1(b)      Domestic Financial Institutions(Banks/ Financial Institutions(FIs)/ Insurance Companies)      -      13,65,750      
1(c)      Mutual Funds      -      1,71,96,810      
1(D)      Others      -      14,14,940      

That's interesting

Retail not participate threw own money

But retail participate threw mutual fund who invested retail public money

GLAND PHARMA LTD
Last updated on
11 Nov 2020 | 06:00:00 PM
Sr.No.      Category      No.of shares offered / reserved      No. of shares bid for      No. of times of total meant for the category
1      Qualified Institutional Buyers (QIBs)      86,39,394      4,15,52,830      4.8097
1(a)      Foreign Institutional Investors (FIIs)      -      2,15,75,330      
1(b)      Domestic Financial Institutions(Banks/ Financial Institutions(FIs)/ Insurance Companies)      -      13,65,750      
1(c)      Mutual Funds      -      1,71,96,810      
1(D)      Others      -      14,14,940      

Gland Pharma IPO
GMP 14 +/- 1

Sidhu jaisa ho gaya ohh.... Guru

Manipulation in grey market also, by tomorrow grey market price will vanish completely and ipo will open in RED

On listing day, manipulators will sell at low rates and buy the same to bring down the price to the lowest possible artificial level and then do bulk purchase. Retail investors who applied need to be cautious and not fall prey to these tricks.

No one can predict the listing gains. Only thing I can confirm is this is a good stock. Blindly invested for long term as a portfolio stock. Not worrying much on the listing day outcome.

Yeah I think this is a buy and forget kind of share. Hope its lists good too but not worried much about listing. Infact below 1300 it would be a blind buy.

Since QIBs has applied higher bid Rs.1500. Do I need to change my bid to Rs.1500 from Rs.1490 to get the shares alloted. Can anyone answer this?

Yes otherwise app rejected

Ok thanks I would do the change now.

Gland Pharma IPO
GMP 18 +/- 1

Gland Pharma IPO

LAST Day at 3:55PM

The following data is assuming the shares will be issued at @1,500/- (upper price band)

QIB*: 06.40X (*Excluding Anchor)
NII: 00.51X
RII: 00.23X
Total: 02.05X

*RII Applications: 1.98L* Approx
No. of Applic-wise: 00.13X


Gland Pharma IPO
GMP 22 +/- 1

Gland Pharma IPO

LAST Day at 3:45PM

The following data is assuming the shares will be issued at @1,500/- (upper price band)

QIB*: 06.40X (*Excluding Anchor)
NII: 00.40X
RII: 00.23X
Total: 02.03X

*RII Applications: 1.97L* Approx
No. of Applic-wise: 00.13X


Gland Pharma IPO
GMP 28 +/- 1

Gland Pharma IPO

LAST Day at 3:35PM

The following data is assuming the shares will be issued at @1,500/- (upper price band)

QIB*: 06.32X (*Excluding Anchor)
NII: 00.31X
RII: 00.23X
Total: 01.98X

*RII Applications: 1.94L* Approx
No. of Applic-wise: 00.13X


Gland Pharma IPO
GMP 29 +/- 1

What is the expected listing

QIB helps to sail through the IPO. HNI and RII subscriptions 0.19x each.

Big question... who will be the buyer on listing day ?

@omi
Govt of India has fixed limit of 74% investment by foreign investors. Originally Fosun wanted to buy 87%. So they had to scale down.
If Fosun was holding 74% then FII could not have purchased a single share
That is why Fosun is selling upto 1.9 crore shares so translating to FII head room of 1.9 multiplied by 1500 that is equal to 2850 crore. in addition there is additional head room of 74% of Rs 1250 crore fresh issue which is 925 crore. So total foreign holding can be upto 3775 crore at 1500 price. FII had been allotted around 1200 crore in anchor. They must have applied in QIB quota also. Basis that allotment there may be still head room for FII to buy if some domestic QIB or retail or HNI wants to sell on day 1

Hope i have clarified

hi @Arun,

thank you for the clarification. As per this, FII can absorb 2575 crs/1500 rs i.e. around 17 million shares. NII +Retail combined allocation is around 22 million shares. So if both categories remain subscribed less than 0.8X and everyone decides to sell of on listing day, FIIs are still in comfortable position to absorb all supply?

Its a good long term bet when DIIs do not apply & FIIs apply.
It will open positive & slowly scale up not a pop up that DII want

Forget the China link, look at the Business Model & profitability.

Best wishes

Gland Pharma IPO

LAST Day at 2:35PM

The following data is assuming the shares will be issued at @1,500/- (upper price band)

QIB*: 05.49X (*Excluding Anchor)
NII: 00.20X
RII: 00.20X
Total: 01.71X

*RII Applications: 1.73L* Approx
No. of Applic-wise: 00.11X


Gland Pharma IPO
GMP 18 +/- 1

As Retail and HNI will be subscribed below 0.5 times there would not be much selling pressure on listing day. Indeed FII's and QIB's will be looking to corner bulk of the shares as and when Retail and HNI will be selling and most probably the issue will be closed with 10% premium at least on listing day.

Govt of India has fixed limit of 74% investment by foreign investors. Originally Fosun wanted to buy 87%. So they had to scale down.
If Fosun was holding 74% then FII could not have purchased a single share
That is why Fosun is selling upto 1.9 crore shares so translating to FII head room of 1.9 multiplied by 1500 that is equal to 2850 crore. in addition there is additional head room of 74% of Rs 1250 crore fresh issue which is 925 crore. So total foreign holding can be upto 3775 crore at 1500 price. FII had been allotted around 1200 crore in anchor. They must have applied in QIB quota also. Basis that allotment there may be still head room for FII to buy if some domestic QIB or retail or HNI wants to sell on day 1

Will this is be issued at lower price band, given the amount of retail and NII subscription is extremely low ?

May not be. As QIBs has subscribed over 6 times.

no